Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_3
1
13%
Ph phase_4
2
25%
Ph not_applicable
1
13%
Ph early_phase_1
1
13%
Ph phase_1
1
13%
Ph phase_2
2
25%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Withdrawn2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A1 (12.5%)

Trials by Status

completed563%
withdrawn225%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
completedearly_phase_1

Low Dose Fat-Induced Insulin Resistance

NCT03479671
withdrawnphase_2

Role of Intralipid in Management of Organophosphorus Poisoning

NCT04393103
completedphase_3

Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

NCT03387579
recruitingphase_1

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

NCT04328337
completedphase_4

The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns

NCT03857646
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03479671Early Phase 1

Low Dose Fat-Induced Insulin Resistance

Completed
NCT04393103Phase 2

Role of Intralipid in Management of Organophosphorus Poisoning

Withdrawn
NCT03387579Phase 3

Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

Completed
NCT04328337Phase 1

Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

Recruiting
NCT03857646Phase 4

The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns

Completed
NCT04558190Not Applicable

Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

Completed
NCT04274803Phase 4

Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?

Withdrawn
NCT00672854Phase 2

Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8